SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Downloaden Sie, um offline zu lesen
©Dr. Anwar Siddiqui
RENAL
FUNCTION
TESTS
Why test renal function?
 To asses the functional capacity of kidney
 Early detection of possible renal impairment.
 Severity and progression of the impairment.
 Monitor response to treatment
 Monitor the safe and effective use of drugs
which are excreted in the urine
When should we assess renal
function? Older age
 Family history of Chronic Kidney disease (CKD)
 Decreased renal mass
 Low birth weight
 Diabetes Mellitus (DM)
 Hypertension (HTN)
 Autoimmune disease
 Systemic infections
 Urinary tract infections (UTI)
 Nephrolithiasis
 Obstruction to the lower urinary tract
 Drug toxicity
What to examine???
Renal function tests are divided into the
following:
 Urine analysis
 Blood examination
 Glomerular Function Test
 Tubular Function Test
Urine Analysis
 Urine examination is an extremely valuable
and most easily performed test for the
evaluation of renal functions.
 It includes physical or macroscopic
examination, chemical examination and
microscopic examination of the sediment.
Urine analysis continued………
Macroscopic examination
Colour
 Normal- pale yellow in colour due to pigments
urochrome,urobilin and uroerythrin.
 Cloudiness may be caused by excessive cellular
material or protein, crystallization or
precipitation of salts upon standing at room
temperature or in the refrigerator.
 If the sample contains many red blood cells, it
would be cloudy as well as red.
Blue Green Pink-Orange-
Red
Red-brown-black
Methylene Blue Haemoglobin Haemoglobin
Pseudomonas Myoglobin Myoglobin
Riboflavin Phenolpthalein Red blood cells
Porphyrins Homogentisic Acid
Rifampicin L -DOPA
Melanin
Methyldopa
 Colour of urine depending upon it’s constituents.
Volume
 Normal- 1-2.5 L/day
 Oliguria- Urine Output < 400ml/day
Seen in
– Acute glomerulonephritis
– Renal Failure
 Polyuria- Urine Output > 2.5 L/day
Seen in
– Increased water ingestion
– Diabetes mellitus and insipidus.
 Anuria- Urine output < 100ml/day
Seen in renal shut down
Specific Gravity
 Measured by urinometer or refractometer.
 It is measurement of urine density which reflects the
ability of the kidney to concentrate or dilute the urine
relative to the plasma from which it is filtered.
 Normal :- 1.001- 1.040.
S.G Osmolality (mosm/kg)
1.001 100
1.010 300
1.020 800
1.025 1000
1.030 1200
1.040 1400
 Increase in Specific Gravity seen in
 Low water intake
 Diabetes mellitus
 Albuminuruia
 Acute nephritis.
 Decrease in Specific Gravity is seen in
 Absence of ADH
 Renal Tubular damage.
 Isosthenuria-Persistent production of fixed
low Specific gravity urine isoosmolar with
plasma despite variation in water intake.
pH
 Urine pH ranges from 4.5 to 8
 Normally it is slightly acidic lying between 6 –
6.5.
 After meal it becomes alkaline.
 On exposure to atmosphere,urea in urine
splits causing NH4
+ release resulting in alkaline
reaction.
Microscopic examination
 A sample of well-mixed urine (usually 10-15 ml) is
centrifuged in a test tube at relatively low speed
(about 2000-3,000 rpm) for 5-10 minutes which
produces a concentration of sediment (cellular matter)
at the bottom of the tube.
 A drop of sediment is poured onto a glass slide and a
thin slice of glass (a coverslip) is place over it.
 The sediment is first examined under low power to
identify crystals, casts, squamous cells, and other large
objects. "Casts" are plugs of material which came from
individual tubules.
 The numbers of casts seen are usually reported as
number of each type found per low power field (LPF).
For an example: "5-10 hyaline casts/L casts/LPF."
 Then, examination is carried out at high power to identify
crystals, cells, and bacteria.
 The various types of cells are usually described as the
number of each type found per average high power field
(HPF). For example: "1-5 WBC/HPF."
 Epithelial cells and 1-2 WBC or pus cell/HPF is normally
seen
 If more leukocytes per each high power field appear in non-
contaminated urine, the specimen is probably abnormal showing
pyuria. Leukocytes have lobed nuclei and granular cytoplasm.
 Usually, the WBC's are granulocytes. White cells from the vagina,
in the presence of vaginal and cervical infections, or the external
urethral meatus in men and women may contaminate the urine.
 Presence of Granular Casts, RBC, bacteria, Glucose, Albumin
and Ketone bodies is abnormal.
 Hematuria is the presence of abnormal numbers of red cells
in urine due to any of several possible causes.
– glomerular damage,
– tumors which erode the urinary tract anywhere along its length,
– kidney trauma,
– urinary tract stones,
– acute tubular necrosis,
– upper and lower urinary tract infections,
– nephrotoxins
 Red blood cells may stick together and form red blood cell
casts. Such casts are indicative of glomerulonephritis, with
leakage of RBC's from glomeruli, or severe tubular damage.
 White blood cell casts are most typical for acute
pyelonephritis, but they may also be present with
glomerulonephritis. Their presence indicates inflammation of
the kidney.
Urinary crystals. (A) Calcium oxalate crystals; (B) uric acid
crystals (C) triple phosphate crystals with amorphous
phosphates ; (D) cystine crystals.
Crystals
 Tyrosine crystals with congenital tyrosinosis
 Leucine crystals in patients with severe liver disease or
with maple syrup urine disease.
Blood examination
 Done to measure substance in blood that are
normally excreted by kidney.
 Their level in blood increases in kidney
dysfunction.
 As markers of renal function creatinine, urea,uric
acid and electrolytes are done for routine
analysis
Serum creatinine
 Creatinine is a breakdown product of creatine
phosphate in muscle, and is usually produced at a fairly
constant rate by the body depending on muscle mass
 Creatinine is filtered but not reabsorbed in kidney.
 Normal range is 0.8-1.3 mg/dl in men and 0.6-1 mg/dl
in women.
 Not increased above normal until GFR<50 ml/min .
 The methods most widely used for serum creatinine
are based on the Jaffe reaction. This reaction occurs
between creatinine and the picrate ion formed in
alkaline medium (sodium picrate); a red-orange
solution develops which is read colorimetrically at 520
nm .
• Increased serum creatinine:
– Impaired renal function
– Very high protein diet
– Anabolic steroid users
– Vary large muscle mass: body
builders, giants, acromegaly patients
– Rhabdomyolysis/crush injury
– Athletes taking oral creatine.
– Drugs:
• Probenecid
• Cimetidine
• Triamterene
• Trimethoprim
• Amiloride
Blood urea
 Urea is major nitrogenous end product of protein and
amino acid catabolism, produced by liver and
distributed throughout intracellular and extracellular
fluid.
 Urea is filtered freely by the glomeruli .
 Many renal diseases with various glomerular, tubular,
interstitial or vascular damage can cause an increase in
plasma urea concentration.
 The reference interval for serum urea of healthy adults
is 10-40 mg/dl.
 Plasma concentrations also tend to be slightly higher in
males than females. High protein diet causes significant
increases in plasma urea concentrations and urinary
excretion.
 Measurement of plasma creatinine provides a more
accurate assessment than urea because there are
many non renal factors that affect urea level.
 Nonrenal factors can affect the urea level (normal
adults is level 10-40mg/dl) like:
 Mild dehydration,
 high protein diet,
 increased protein catabolism, muscle wasting as in starvation,
 reabsorption of blood proteins after a GIT haemorrhage,
 treatment with cortisol or its synthetic analogous
 States associated with elevated levels of urea in blood
are referred to as uremia or azotemia.
 Causes of urea plasma elevations:
 Prerenal: renal hypoperfusion
 Renal: acute tubular necrosis
 Postrenal: obstruction of urinary flow
 Blood urea is normally doubled when the GFR is halved.
 Parallel determination of urea and creatinine is performed
to differentiate between pre-renal and post-renal
azotemia.
 Pre-renal azotemia leads to increased urea levels, while
creatinine values remain within the reference range. In
post-renal azotemias both urea and creatinine levels rise,
but creatinine in a smaller extent.
 Enzymatic Berthelot Method is used for blood urea
estimation:
 Principal:
 Urea + H2O Urease > Ammonia + CO2
 Ammonia + Phenolic Chromogen + Hypochlorite > Green Colored
Complex whoose absorbance is read at 570nm
Serum Uric Acid
 In human, uric acid is the major product of the
catabolism of the purine nucleosides, adenosine and
guanosine.
 Purines are derived from catabolism of dietary nucleic
acid and from degradation of endogenous nucleic
acids.
 Overproduction of uric acid may result from increased
synthesis of purine precursors.
 In humans, approximately 75% of uric acid excreted is
lost in the urine; most of the reminder is secreted into
the GIT
 Renal handling of uric acid is complex and involves
four sequential steps:
– Glomerular filtration of virtually all the uric acid in
capillary plasma entering the glomerulus.
– Reabsorption in the proximal convoluted tubule of
about 98 to 100% of filtered uric acid.
– Subsequent secretion of uric acid into the lumen of
the distal portion of the proximal tubule.
– Further reabsorption in the distal tubule.
 Hyperuricemia is defined by serum or plasma uric
acid concentrations higher than 7.0 mg/dl
(0.42mmol/L) in men or greater than 6.0 mg/dl
(0.36mmol/L) in women
Glomerular function tests
 The GFR is the best measure of glomerular function.
 Normal GFR is approximately 125 mL/min
 When GFR decreases to 30% of normal moderate
renal insufficiency. Patients remain asymptomatic with
only biochemical evidence of a decline in GFR
 As the GFR decreases further severe renal
insufficiency characterized by profound clinical
manifestations of uremia and biochemical abnormalities,
such as acidemia; volume overload; and neurologic,
cardiac, and respiratory manifestations
 When GFR is 5% to 10% of normal ESRD
 Inulin clearance and creatinine clearance are used to
measure the GFR.
Creatinine Clearance:
 A simple, inexpensive bedside estimate of GFR.
 GFR= Ccr = {Ucr * Urinary flow rate(ml/min)} / Pcr
Normal 100-120ml/min
Dec.Renal reserve 60-100ml/min
Mild Renal imp 40-60ml/min
Moderate insuff. 25-40ml/min
Renal failure <25ml/min
ESRD <10ml/min
 Cockroft Gault Formula
Creatinine Clearance =(140-age)* weight in kg / S.creat.*72
(multiplied by 0.85 for females)
 MDRD Nomogram
GFR(ml/min)=170*S.creat.-0.999 *age-0.176 * BUN-0.170 *albumin0.318
(multiplied by 0.742 if female)
Tubular function tests
Urine Concentration Test
 The ability of the kidney to concentrate urine is a test
of tubular function that can be carried out readily
with only minor inconvenience to the patient.
 This test requires a water deprivation for 14 hrs in
healthy individuals.
 A specific gravity of > 1.02 indicates normal
concentrating power.
 Specific gravity of 1.008 to 1.010 is isotonic with
plasma and indicates no work done by kidneys.
 The test should not be performed on a dehydrated
patient.
Vasopressin Test
 More patient friendly than water deprivation test.
 The subject has nothing to drink after 6 p.m. At 8 p.m.
five units of vasopressin tannate is injected
subcutaneously. All urine samples are collected
separately until 9 a.m. the next morning.
 Satisfactory concentration is shown by at least one
sample having a specific gravity above 1.020, or an
osmolality above 800 m osm/kg.
 The urine/plasma osmolality ratio should reach 3 and
values less than 2 are abnormal.
Urine Dilution (Water Load) Test
 After an overnight fast the subject empties his bladder
completely and is given 1000 ml of water to drink.
 Urine specimens are collected for the next 4 hours, the
patient emptying bladder completely on each
occasion.
 Normally the patient will excrete at least 700 ml of
urine in the 4 hours, and at least one specimen will
have a specific gravity less than 1.004.
 Kidneys which are severely damaged cannot excrete a
urine of lower specific gravity than 1.010 or a volume
above 400 ml in this time.
 The test should not be done if there is oedema or renal
failure; water intoxication may result.
Para Aminohippuric Acid Clearance
 Maximum secretory capacity of tubules for PAH is
nearly constantat about 80mg/min.
 A decrease in the TmPAH indicates tubular damage.
Micropuncturing
 Micropuncturing various part of tubule and analysis of
fluid for volume and composition.
Microcryoscopic study
 Studying slices of renal tissue at different depths.
Microelectrode study
 Measuring membrane potential of the tubular cells
Clinical significance of RFT
in AKI The RIFLE criteria, proposed by the Acute Dialysis Quality
Initiative (ADQI) group, aid in the staging of patients with AKI
(previously ARF).
Addendum
Novel marker for non-invasive estimation of
Glomerular Filtration Rate and Early Renal
Impairment- Cystatin C
• Cystatin C is a nonglycosylated basic protein produced at a
constant rate by all investigated nucleated cells.
• It is freely filtered by the renal glomeruli and primarily
catabolized in the tubuli (not secreted or reabsorbed as an
intact molecule).
• As serum cystatin C concentration is independent of age, sex,
and muscle mass, it has been postulated to be an improved
marker of glomerular filtration rate (GFR) compared with
serum creatinine level. (Carlo D, Annalisa L. Serum Cystatin as a
Marker of Glomerular Filtration RateAmerican Journal of Kidney
Diseases, Volume 37, Issue 2, February 2009, Pages 448-450)
Renal Function Test
Renal Function Test

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Renal Function Tests (RFT)
Renal Function Tests (RFT)Renal Function Tests (RFT)
Renal Function Tests (RFT)
 
kidney function tests
kidney function testskidney function tests
kidney function tests
 
Lipid profile test ppt
Lipid profile test pptLipid profile test ppt
Lipid profile test ppt
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
glucose tolerance test indication and procedure
glucose tolerance test  indication and procedureglucose tolerance test  indication and procedure
glucose tolerance test indication and procedure
 
Lipid profile test
Lipid profile testLipid profile test
Lipid profile test
 
FATTY LIVER
FATTY LIVERFATTY LIVER
FATTY LIVER
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Cardiac biomarkers - I
Cardiac biomarkers  - ICardiac biomarkers  - I
Cardiac biomarkers - I
 
Coagulation tests
Coagulation testsCoagulation tests
Coagulation tests
 
Kidney function tests
Kidney function testsKidney function tests
Kidney function tests
 
Metabolism of bilurubin
Metabolism of bilurubinMetabolism of bilurubin
Metabolism of bilurubin
 
LIVER FUNCTIONS TESTS -1-
LIVER FUNCTIONS TESTS -1-LIVER FUNCTIONS TESTS -1-
LIVER FUNCTIONS TESTS -1-
 
Gastric function tests
Gastric function testsGastric function tests
Gastric function tests
 
creatinine clearance test
creatinine clearance testcreatinine clearance test
creatinine clearance test
 
sgot and sgpt
sgot and sgptsgot and sgpt
sgot and sgpt
 
Fatty liver
Fatty liverFatty liver
Fatty liver
 
Hyperglycemia
HyperglycemiaHyperglycemia
Hyperglycemia
 
Creatinine clearance
Creatinine clearanceCreatinine clearance
Creatinine clearance
 
LIVER ENZYMES AST, ALT & ALP
LIVER ENZYMES AST, ALT & ALPLIVER ENZYMES AST, ALT & ALP
LIVER ENZYMES AST, ALT & ALP
 

Andere mochten auch

Renal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur PuriRenal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur PuriAnkur Puri
 
Gastrointestinal disease
Gastrointestinal diseaseGastrointestinal disease
Gastrointestinal diseaseIAU Dent
 
GASTRIC FUNCTION TESTS
GASTRIC FUNCTION TESTS GASTRIC FUNCTION TESTS
GASTRIC FUNCTION TESTS YESANNA
 
Gastrointestinal disease lecture(ppt)
Gastrointestinal disease lecture(ppt)Gastrointestinal disease lecture(ppt)
Gastrointestinal disease lecture(ppt)Razavi Nader
 
Gastrointestinal System Disorders
Gastrointestinal System DisordersGastrointestinal System Disorders
Gastrointestinal System DisordersJessie Madz
 
Renal biopsy, nadia
Renal biopsy, nadiaRenal biopsy, nadia
Renal biopsy, nadiaFarragBahbah
 
Focal Glomerulosclerosis
Focal GlomerulosclerosisFocal Glomerulosclerosis
Focal Glomerulosclerosisedwinchowyw
 
Renal Replacement Therapies
Renal Replacement TherapiesRenal Replacement Therapies
Renal Replacement Therapiesaungp
 
Kidney function test
Kidney function testKidney function test
Kidney function testGavin Yap
 
Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...
Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...
Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...PAWAN V. KULKARNI
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapynagarjunanri
 
Hepatitis C in kidney transplantation
Hepatitis C in kidney transplantationHepatitis C in kidney transplantation
Hepatitis C in kidney transplantationSalwa Ibrahim
 
Kidney disorders, Laboratory Investigation and Renal Function Tests
Kidney disorders, Laboratory Investigation and Renal Function TestsKidney disorders, Laboratory Investigation and Renal Function Tests
Kidney disorders, Laboratory Investigation and Renal Function TestsMadhukar Vedantham
 

Andere mochten auch (20)

Renal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur PuriRenal Function Tests by Dr.Ankur Puri
Renal Function Tests by Dr.Ankur Puri
 
Gastrointestinal disease
Gastrointestinal diseaseGastrointestinal disease
Gastrointestinal disease
 
GASTRIC FUNCTION TESTS
GASTRIC FUNCTION TESTS GASTRIC FUNCTION TESTS
GASTRIC FUNCTION TESTS
 
Gastrointestinal disease lecture(ppt)
Gastrointestinal disease lecture(ppt)Gastrointestinal disease lecture(ppt)
Gastrointestinal disease lecture(ppt)
 
Gastrointestinal System Disorders
Gastrointestinal System DisordersGastrointestinal System Disorders
Gastrointestinal System Disorders
 
Renal biopsy, nadia
Renal biopsy, nadiaRenal biopsy, nadia
Renal biopsy, nadia
 
Renal biopsy
Renal biopsyRenal biopsy
Renal biopsy
 
Focal Glomerulosclerosis
Focal GlomerulosclerosisFocal Glomerulosclerosis
Focal Glomerulosclerosis
 
Renal Replacement therapy
Renal Replacement therapyRenal Replacement therapy
Renal Replacement therapy
 
Renal Replacement Therapies
Renal Replacement TherapiesRenal Replacement Therapies
Renal Replacement Therapies
 
Cystic disease of the kidney
Cystic disease of the kidneyCystic disease of the kidney
Cystic disease of the kidney
 
Kidney
KidneyKidney
Kidney
 
Fsgs
FsgsFsgs
Fsgs
 
Kidney function test
Kidney function testKidney function test
Kidney function test
 
Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...
Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...
Review of new alerts on PROTON PUMP INHIBITORS (PPI) adverse effects 2016 UPD...
 
Obstructive uropathy+urolithias
Obstructive uropathy+urolithiasObstructive uropathy+urolithias
Obstructive uropathy+urolithias
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Hepatitis C in kidney transplantation
Hepatitis C in kidney transplantationHepatitis C in kidney transplantation
Hepatitis C in kidney transplantation
 
Kidney disorders, Laboratory Investigation and Renal Function Tests
Kidney disorders, Laboratory Investigation and Renal Function TestsKidney disorders, Laboratory Investigation and Renal Function Tests
Kidney disorders, Laboratory Investigation and Renal Function Tests
 
Nsf
NsfNsf
Nsf
 

Ähnlich wie Renal Function Test

Ähnlich wie Renal Function Test (20)

Renal function test
Renal function testRenal function test
Renal function test
 
A detailed explanation of kidney function tests.ppt
A detailed explanation of kidney function tests.pptA detailed explanation of kidney function tests.ppt
A detailed explanation of kidney function tests.ppt
 
Renal function test
Renal function testRenal function test
Renal function test
 
Renal function test
Renal function testRenal function test
Renal function test
 
GUE.pptx
GUE.pptxGUE.pptx
GUE.pptx
 
Acute Kidney Injury.pptx
Acute Kidney Injury.pptxAcute Kidney Injury.pptx
Acute Kidney Injury.pptx
 
5. Renal Function Tests.pptx
5. Renal Function Tests.pptx5. Renal Function Tests.pptx
5. Renal Function Tests.pptx
 
Renal function tests - Dr. K. Santha
Renal function tests  - Dr. K. SanthaRenal function tests  - Dr. K. Santha
Renal function tests - Dr. K. Santha
 
Renal function tests Dr.K.Santha
Renal function tests  Dr.K.SanthaRenal function tests  Dr.K.Santha
Renal function tests Dr.K.Santha
 
Applied aspects of Kidney and RFT by Dr. MP.pptx
Applied aspects of Kidney and RFT by Dr. MP.pptxApplied aspects of Kidney and RFT by Dr. MP.pptx
Applied aspects of Kidney and RFT by Dr. MP.pptx
 
RENAL FUNCTION TESTS
RENAL FUNCTION TESTSRENAL FUNCTION TESTS
RENAL FUNCTION TESTS
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Approach To Patient With Abnormal Urine Findings.pdf
Approach To Patient With Abnormal Urine Findings.pdfApproach To Patient With Abnormal Urine Findings.pdf
Approach To Patient With Abnormal Urine Findings.pdf
 
Renal function
Renal functionRenal function
Renal function
 
Lecture 15 kidney- pathology
Lecture 15 kidney- pathology Lecture 15 kidney- pathology
Lecture 15 kidney- pathology
 
renal function tests by Dr siva kumar
renal function tests by Dr siva kumarrenal function tests by Dr siva kumar
renal function tests by Dr siva kumar
 
KIDNEY FUNCTION TEST
KIDNEY FUNCTION TESTKIDNEY FUNCTION TEST
KIDNEY FUNCTION TEST
 
Renal disase [autosaved]
Renal disase [autosaved]Renal disase [autosaved]
Renal disase [autosaved]
 
Urine R/E and RFTs
Urine R/E and RFTsUrine R/E and RFTs
Urine R/E and RFTs
 
Kamal
KamalKamal
Kamal
 

Mehr von Anwar Siddiqui

DRUG ABUSE PREVENTION PROGRAM.pptx
DRUG ABUSE PREVENTION PROGRAM.pptxDRUG ABUSE PREVENTION PROGRAM.pptx
DRUG ABUSE PREVENTION PROGRAM.pptxAnwar Siddiqui
 
Drugs / Substance Abuse
Drugs / Substance AbuseDrugs / Substance Abuse
Drugs / Substance AbuseAnwar Siddiqui
 
Smart research thorough online tools.pdf
Smart research thorough online tools.pdfSmart research thorough online tools.pdf
Smart research thorough online tools.pdfAnwar Siddiqui
 
Drugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptxDrugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptxAnwar Siddiqui
 
Excitable Tissues, Resting Membrane Potential & Action.pptx
Excitable Tissues, Resting Membrane Potential & Action.pptxExcitable Tissues, Resting Membrane Potential & Action.pptx
Excitable Tissues, Resting Membrane Potential & Action.pptxAnwar Siddiqui
 
Types of muscle bioengeenring.pptx
Types of muscle bioengeenring.pptxTypes of muscle bioengeenring.pptx
Types of muscle bioengeenring.pptxAnwar Siddiqui
 
Body composition analysis
Body composition analysisBody composition analysis
Body composition analysisAnwar Siddiqui
 
Introduction to exercise testing
Introduction to exercise testingIntroduction to exercise testing
Introduction to exercise testingAnwar Siddiqui
 
Respiratory acidosis and alkalosis
Respiratory acidosis and alkalosisRespiratory acidosis and alkalosis
Respiratory acidosis and alkalosisAnwar Siddiqui
 
Fetal and neonatal physiology
Fetal and neonatal physiologyFetal and neonatal physiology
Fetal and neonatal physiologyAnwar Siddiqui
 
Osmotic fragility &amp; rbc membrane defects 050916
Osmotic fragility &amp; rbc membrane defects 050916Osmotic fragility &amp; rbc membrane defects 050916
Osmotic fragility &amp; rbc membrane defects 050916Anwar Siddiqui
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial InfarctionAnwar Siddiqui
 
Peripheral Blood Smear
Peripheral Blood SmearPeripheral Blood Smear
Peripheral Blood SmearAnwar Siddiqui
 
In vitro fertilization
In vitro fertilizationIn vitro fertilization
In vitro fertilizationAnwar Siddiqui
 
Research methodology iii
Research methodology iiiResearch methodology iii
Research methodology iiiAnwar Siddiqui
 
Research Methodology Part II
Research Methodology Part IIResearch Methodology Part II
Research Methodology Part IIAnwar Siddiqui
 

Mehr von Anwar Siddiqui (20)

DRUG ABUSE PREVENTION PROGRAM.pptx
DRUG ABUSE PREVENTION PROGRAM.pptxDRUG ABUSE PREVENTION PROGRAM.pptx
DRUG ABUSE PREVENTION PROGRAM.pptx
 
Drugs / Substance Abuse
Drugs / Substance AbuseDrugs / Substance Abuse
Drugs / Substance Abuse
 
Smart research thorough online tools.pdf
Smart research thorough online tools.pdfSmart research thorough online tools.pdf
Smart research thorough online tools.pdf
 
Drugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptxDrugs presentation 9.12.19.pptx
Drugs presentation 9.12.19.pptx
 
Excitable Tissues, Resting Membrane Potential & Action.pptx
Excitable Tissues, Resting Membrane Potential & Action.pptxExcitable Tissues, Resting Membrane Potential & Action.pptx
Excitable Tissues, Resting Membrane Potential & Action.pptx
 
Types of muscle bioengeenring.pptx
Types of muscle bioengeenring.pptxTypes of muscle bioengeenring.pptx
Types of muscle bioengeenring.pptx
 
ECG1.pptx
ECG1.pptxECG1.pptx
ECG1.pptx
 
ecg 3.pptx
ecg 3.pptxecg 3.pptx
ecg 3.pptx
 
History taking
History takingHistory taking
History taking
 
Body composition analysis
Body composition analysisBody composition analysis
Body composition analysis
 
Introduction to exercise testing
Introduction to exercise testingIntroduction to exercise testing
Introduction to exercise testing
 
Respiratory acidosis and alkalosis
Respiratory acidosis and alkalosisRespiratory acidosis and alkalosis
Respiratory acidosis and alkalosis
 
Fetal and neonatal physiology
Fetal and neonatal physiologyFetal and neonatal physiology
Fetal and neonatal physiology
 
Al hijamah
Al hijamahAl hijamah
Al hijamah
 
Osmotic fragility &amp; rbc membrane defects 050916
Osmotic fragility &amp; rbc membrane defects 050916Osmotic fragility &amp; rbc membrane defects 050916
Osmotic fragility &amp; rbc membrane defects 050916
 
Acute Myocardial Infarction
Acute Myocardial InfarctionAcute Myocardial Infarction
Acute Myocardial Infarction
 
Peripheral Blood Smear
Peripheral Blood SmearPeripheral Blood Smear
Peripheral Blood Smear
 
In vitro fertilization
In vitro fertilizationIn vitro fertilization
In vitro fertilization
 
Research methodology iii
Research methodology iiiResearch methodology iii
Research methodology iii
 
Research Methodology Part II
Research Methodology Part IIResearch Methodology Part II
Research Methodology Part II
 

Renal Function Test

  • 2. Why test renal function?  To asses the functional capacity of kidney  Early detection of possible renal impairment.  Severity and progression of the impairment.  Monitor response to treatment  Monitor the safe and effective use of drugs which are excreted in the urine
  • 3. When should we assess renal function? Older age  Family history of Chronic Kidney disease (CKD)  Decreased renal mass  Low birth weight  Diabetes Mellitus (DM)  Hypertension (HTN)  Autoimmune disease  Systemic infections  Urinary tract infections (UTI)  Nephrolithiasis  Obstruction to the lower urinary tract  Drug toxicity
  • 4. What to examine??? Renal function tests are divided into the following:  Urine analysis  Blood examination  Glomerular Function Test  Tubular Function Test
  • 5. Urine Analysis  Urine examination is an extremely valuable and most easily performed test for the evaluation of renal functions.  It includes physical or macroscopic examination, chemical examination and microscopic examination of the sediment.
  • 6. Urine analysis continued……… Macroscopic examination Colour  Normal- pale yellow in colour due to pigments urochrome,urobilin and uroerythrin.  Cloudiness may be caused by excessive cellular material or protein, crystallization or precipitation of salts upon standing at room temperature or in the refrigerator.  If the sample contains many red blood cells, it would be cloudy as well as red.
  • 7. Blue Green Pink-Orange- Red Red-brown-black Methylene Blue Haemoglobin Haemoglobin Pseudomonas Myoglobin Myoglobin Riboflavin Phenolpthalein Red blood cells Porphyrins Homogentisic Acid Rifampicin L -DOPA Melanin Methyldopa  Colour of urine depending upon it’s constituents.
  • 8. Volume  Normal- 1-2.5 L/day  Oliguria- Urine Output < 400ml/day Seen in – Acute glomerulonephritis – Renal Failure  Polyuria- Urine Output > 2.5 L/day Seen in – Increased water ingestion – Diabetes mellitus and insipidus.  Anuria- Urine output < 100ml/day Seen in renal shut down
  • 9. Specific Gravity  Measured by urinometer or refractometer.  It is measurement of urine density which reflects the ability of the kidney to concentrate or dilute the urine relative to the plasma from which it is filtered.  Normal :- 1.001- 1.040. S.G Osmolality (mosm/kg) 1.001 100 1.010 300 1.020 800 1.025 1000 1.030 1200 1.040 1400
  • 10.  Increase in Specific Gravity seen in  Low water intake  Diabetes mellitus  Albuminuruia  Acute nephritis.  Decrease in Specific Gravity is seen in  Absence of ADH  Renal Tubular damage.  Isosthenuria-Persistent production of fixed low Specific gravity urine isoosmolar with plasma despite variation in water intake.
  • 11. pH  Urine pH ranges from 4.5 to 8  Normally it is slightly acidic lying between 6 – 6.5.  After meal it becomes alkaline.  On exposure to atmosphere,urea in urine splits causing NH4 + release resulting in alkaline reaction.
  • 12. Microscopic examination  A sample of well-mixed urine (usually 10-15 ml) is centrifuged in a test tube at relatively low speed (about 2000-3,000 rpm) for 5-10 minutes which produces a concentration of sediment (cellular matter) at the bottom of the tube.  A drop of sediment is poured onto a glass slide and a thin slice of glass (a coverslip) is place over it.  The sediment is first examined under low power to identify crystals, casts, squamous cells, and other large objects. "Casts" are plugs of material which came from individual tubules.  The numbers of casts seen are usually reported as number of each type found per low power field (LPF). For an example: "5-10 hyaline casts/L casts/LPF."
  • 13.  Then, examination is carried out at high power to identify crystals, cells, and bacteria.  The various types of cells are usually described as the number of each type found per average high power field (HPF). For example: "1-5 WBC/HPF."  Epithelial cells and 1-2 WBC or pus cell/HPF is normally seen  If more leukocytes per each high power field appear in non- contaminated urine, the specimen is probably abnormal showing pyuria. Leukocytes have lobed nuclei and granular cytoplasm.  Usually, the WBC's are granulocytes. White cells from the vagina, in the presence of vaginal and cervical infections, or the external urethral meatus in men and women may contaminate the urine.
  • 14.  Presence of Granular Casts, RBC, bacteria, Glucose, Albumin and Ketone bodies is abnormal.  Hematuria is the presence of abnormal numbers of red cells in urine due to any of several possible causes. – glomerular damage, – tumors which erode the urinary tract anywhere along its length, – kidney trauma, – urinary tract stones, – acute tubular necrosis, – upper and lower urinary tract infections, – nephrotoxins  Red blood cells may stick together and form red blood cell casts. Such casts are indicative of glomerulonephritis, with leakage of RBC's from glomeruli, or severe tubular damage.  White blood cell casts are most typical for acute pyelonephritis, but they may also be present with glomerulonephritis. Their presence indicates inflammation of the kidney.
  • 15.
  • 16. Urinary crystals. (A) Calcium oxalate crystals; (B) uric acid crystals (C) triple phosphate crystals with amorphous phosphates ; (D) cystine crystals. Crystals  Tyrosine crystals with congenital tyrosinosis  Leucine crystals in patients with severe liver disease or with maple syrup urine disease.
  • 17. Blood examination  Done to measure substance in blood that are normally excreted by kidney.  Their level in blood increases in kidney dysfunction.  As markers of renal function creatinine, urea,uric acid and electrolytes are done for routine analysis
  • 18. Serum creatinine  Creatinine is a breakdown product of creatine phosphate in muscle, and is usually produced at a fairly constant rate by the body depending on muscle mass  Creatinine is filtered but not reabsorbed in kidney.  Normal range is 0.8-1.3 mg/dl in men and 0.6-1 mg/dl in women.  Not increased above normal until GFR<50 ml/min .  The methods most widely used for serum creatinine are based on the Jaffe reaction. This reaction occurs between creatinine and the picrate ion formed in alkaline medium (sodium picrate); a red-orange solution develops which is read colorimetrically at 520 nm .
  • 19. • Increased serum creatinine: – Impaired renal function – Very high protein diet – Anabolic steroid users – Vary large muscle mass: body builders, giants, acromegaly patients – Rhabdomyolysis/crush injury – Athletes taking oral creatine. – Drugs: • Probenecid • Cimetidine • Triamterene • Trimethoprim • Amiloride
  • 20. Blood urea  Urea is major nitrogenous end product of protein and amino acid catabolism, produced by liver and distributed throughout intracellular and extracellular fluid.  Urea is filtered freely by the glomeruli .  Many renal diseases with various glomerular, tubular, interstitial or vascular damage can cause an increase in plasma urea concentration.  The reference interval for serum urea of healthy adults is 10-40 mg/dl.  Plasma concentrations also tend to be slightly higher in males than females. High protein diet causes significant increases in plasma urea concentrations and urinary excretion.
  • 21.  Measurement of plasma creatinine provides a more accurate assessment than urea because there are many non renal factors that affect urea level.  Nonrenal factors can affect the urea level (normal adults is level 10-40mg/dl) like:  Mild dehydration,  high protein diet,  increased protein catabolism, muscle wasting as in starvation,  reabsorption of blood proteins after a GIT haemorrhage,  treatment with cortisol or its synthetic analogous  States associated with elevated levels of urea in blood are referred to as uremia or azotemia.  Causes of urea plasma elevations:  Prerenal: renal hypoperfusion  Renal: acute tubular necrosis  Postrenal: obstruction of urinary flow
  • 22.  Blood urea is normally doubled when the GFR is halved.  Parallel determination of urea and creatinine is performed to differentiate between pre-renal and post-renal azotemia.  Pre-renal azotemia leads to increased urea levels, while creatinine values remain within the reference range. In post-renal azotemias both urea and creatinine levels rise, but creatinine in a smaller extent.  Enzymatic Berthelot Method is used for blood urea estimation:  Principal:  Urea + H2O Urease > Ammonia + CO2  Ammonia + Phenolic Chromogen + Hypochlorite > Green Colored Complex whoose absorbance is read at 570nm
  • 23. Serum Uric Acid  In human, uric acid is the major product of the catabolism of the purine nucleosides, adenosine and guanosine.  Purines are derived from catabolism of dietary nucleic acid and from degradation of endogenous nucleic acids.  Overproduction of uric acid may result from increased synthesis of purine precursors.  In humans, approximately 75% of uric acid excreted is lost in the urine; most of the reminder is secreted into the GIT
  • 24.  Renal handling of uric acid is complex and involves four sequential steps: – Glomerular filtration of virtually all the uric acid in capillary plasma entering the glomerulus. – Reabsorption in the proximal convoluted tubule of about 98 to 100% of filtered uric acid. – Subsequent secretion of uric acid into the lumen of the distal portion of the proximal tubule. – Further reabsorption in the distal tubule.  Hyperuricemia is defined by serum or plasma uric acid concentrations higher than 7.0 mg/dl (0.42mmol/L) in men or greater than 6.0 mg/dl (0.36mmol/L) in women
  • 25. Glomerular function tests  The GFR is the best measure of glomerular function.  Normal GFR is approximately 125 mL/min  When GFR decreases to 30% of normal moderate renal insufficiency. Patients remain asymptomatic with only biochemical evidence of a decline in GFR  As the GFR decreases further severe renal insufficiency characterized by profound clinical manifestations of uremia and biochemical abnormalities, such as acidemia; volume overload; and neurologic, cardiac, and respiratory manifestations  When GFR is 5% to 10% of normal ESRD
  • 26.  Inulin clearance and creatinine clearance are used to measure the GFR. Creatinine Clearance:  A simple, inexpensive bedside estimate of GFR.  GFR= Ccr = {Ucr * Urinary flow rate(ml/min)} / Pcr Normal 100-120ml/min Dec.Renal reserve 60-100ml/min Mild Renal imp 40-60ml/min Moderate insuff. 25-40ml/min Renal failure <25ml/min ESRD <10ml/min
  • 27.  Cockroft Gault Formula Creatinine Clearance =(140-age)* weight in kg / S.creat.*72 (multiplied by 0.85 for females)  MDRD Nomogram GFR(ml/min)=170*S.creat.-0.999 *age-0.176 * BUN-0.170 *albumin0.318 (multiplied by 0.742 if female)
  • 28. Tubular function tests Urine Concentration Test  The ability of the kidney to concentrate urine is a test of tubular function that can be carried out readily with only minor inconvenience to the patient.  This test requires a water deprivation for 14 hrs in healthy individuals.  A specific gravity of > 1.02 indicates normal concentrating power.  Specific gravity of 1.008 to 1.010 is isotonic with plasma and indicates no work done by kidneys.  The test should not be performed on a dehydrated patient.
  • 29. Vasopressin Test  More patient friendly than water deprivation test.  The subject has nothing to drink after 6 p.m. At 8 p.m. five units of vasopressin tannate is injected subcutaneously. All urine samples are collected separately until 9 a.m. the next morning.  Satisfactory concentration is shown by at least one sample having a specific gravity above 1.020, or an osmolality above 800 m osm/kg.  The urine/plasma osmolality ratio should reach 3 and values less than 2 are abnormal.
  • 30. Urine Dilution (Water Load) Test  After an overnight fast the subject empties his bladder completely and is given 1000 ml of water to drink.  Urine specimens are collected for the next 4 hours, the patient emptying bladder completely on each occasion.  Normally the patient will excrete at least 700 ml of urine in the 4 hours, and at least one specimen will have a specific gravity less than 1.004.  Kidneys which are severely damaged cannot excrete a urine of lower specific gravity than 1.010 or a volume above 400 ml in this time.  The test should not be done if there is oedema or renal failure; water intoxication may result.
  • 31. Para Aminohippuric Acid Clearance  Maximum secretory capacity of tubules for PAH is nearly constantat about 80mg/min.  A decrease in the TmPAH indicates tubular damage. Micropuncturing  Micropuncturing various part of tubule and analysis of fluid for volume and composition. Microcryoscopic study  Studying slices of renal tissue at different depths. Microelectrode study  Measuring membrane potential of the tubular cells
  • 32. Clinical significance of RFT in AKI The RIFLE criteria, proposed by the Acute Dialysis Quality Initiative (ADQI) group, aid in the staging of patients with AKI (previously ARF).
  • 33. Addendum Novel marker for non-invasive estimation of Glomerular Filtration Rate and Early Renal Impairment- Cystatin C • Cystatin C is a nonglycosylated basic protein produced at a constant rate by all investigated nucleated cells. • It is freely filtered by the renal glomeruli and primarily catabolized in the tubuli (not secreted or reabsorbed as an intact molecule). • As serum cystatin C concentration is independent of age, sex, and muscle mass, it has been postulated to be an improved marker of glomerular filtration rate (GFR) compared with serum creatinine level. (Carlo D, Annalisa L. Serum Cystatin as a Marker of Glomerular Filtration RateAmerican Journal of Kidney Diseases, Volume 37, Issue 2, February 2009, Pages 448-450)